US Patent Issued to Bristol-Myers Squibb on Aug. 19 for "Benzo[5,6[1,4dioxino[2,3-bpyridine compounds useful as IRAK4 inhibitors" (New Jersey Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,702, issued on Aug. 19, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Benzo[5,6[1,4dioxino[2,3-bpyridine compounds useful as IRAK4 inhibitors" was invented by Lidet A. Negash (Plainsboro, N.J.) and Saleem Ahmad (Wall, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of Formula (I) or a salt or prodrug thereof, wherein R1, R2, and R3 are defined herein. Also disclosed are methods of using such compounds as modulators of IRAK4, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases, or in the treatment of ca...